Welch Allyn Holdings, Inc. Sustainability Profile
Welch Allyn Holdings, Inc., a prominent name in the medical device industry, is headquartered in the United States. Founded in 1915, the company has established itself as a leader in diagnostic and therapeutic equipment, primarily serving healthcare professionals across various settings. With a strong presence in North America and Europe, Welch Allyn is renowned for its innovative products, including vital signs monitors, otoscopes, and ophthalmoscopes, which are designed to enhance patient care and streamline clinical workflows. The company has achieved significant milestones, including advancements in digital diagnostics and connectivity solutions that set it apart in the market. Welch Allyn's commitment to quality and innovation has solidified its position as a trusted partner in healthcare, making it a go-to choice for medical practitioners seeking reliable and effective diagnostic tools.
DitchCarbon Score
How does Welch Allyn Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Welch Allyn Holdings, Inc.'s score of 33 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Welch Allyn Holdings, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Hill-Rom Holdings, Inc., which may influence its climate commitments and performance metrics. Emissions data may also be inherited from Baxter International Inc., as part of a cascading relationship. Despite the absence of specific emissions figures, Welch Allyn is part of a broader corporate family that is likely engaged in various climate initiatives. However, there are no documented reduction targets or climate pledges directly associated with Welch Allyn at this time. The lack of specific data highlights the need for transparency and commitment to sustainability within the medical technology sector. As the industry increasingly focuses on reducing carbon footprints, it is essential for Welch Allyn to establish clear climate commitments and reduction targets to align with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2002 | 2003 | 2005 | 2006 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 781,365,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Welch Allyn Holdings, Inc.'s Industry?
How Carbon Intensive is Welch Allyn Holdings, Inc.'s Location?
Welch Allyn Holdings, Inc.'s Scope 3 Categories Breakdown
Welch Allyn Holdings, Inc.'s Scope 3 emissions, which decreased by 10% last year and decreased by approximately 7% since 2009, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 45% of Scope 3 emissions.
Top Scope 3 Categories
Welch Allyn Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Welch Allyn Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
